Literature DB >> 216333

[Monoamine metabolites and cyclic nucleotides in the cerebrospinal fluid of patients with bismuth or mercury poisoning].

H Cramer, B Renaud, M Billiard, J Mouret, R Hammers.   

Abstract

The central metabolism of dopamine, serotonin, cyclic AMP and cyclic GMP was studied by use of the probenecid test in three patients with bismuth encephalopathy and in one patient with mercury encephalopathy. The accumulation of HVA and of cGMP in the cerebrospinal fluid was depressed during the acute phase of bismuth encephalopathy with severe hyposomnia, while it was increased in a patient with regression of clinical symptoms and normal in a patient with more advanced recovery. The patient with chronic mercury poisoning showing a severe cerebellar ataxia and rigidity had an almost complete suppression of HVA accumulation and an increase of cGMP accumulation. No pronounced differences of 5-HIAA and cAMP behavior were found. It is concluded that the central metabolism of dopamine and of cGMP is severely affected in bismuth and mercury encephalopathies.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 216333     DOI: 10.1007/bf00341709

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  23 in total

1.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.

Authors:  A DAHLSTROEM; K FUXE
Journal:  Acta Physiol Scand Suppl       Date:  1964

2.  On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method.

Authors:  N E ANDEN; B E ROOS; B WERDINIUS
Journal:  Life Sci (1962)       Date:  1963-07

3.  [Poisoning by orally administered bismuth salts. Epidemiologic survey].

Authors:  G Martin-Bouyer
Journal:  Therapie       Date:  1976 Nov-Dec       Impact factor: 2.070

4.  Guanosine 3', 5'-cyclicmonophosphate assay at 10(-15)-mole level.

Authors:  H L Cailla; C J Vannier; M A Delaage
Journal:  Anal Biochem       Date:  1976-01       Impact factor: 3.365

5.  Elevation of cyclic GMP levels in central nervous system by excitatory and inhibitory amino acids.

Authors:  J A Ferrendelli; M M Chang; D A Kinscherf
Journal:  J Neurochem       Date:  1974-04       Impact factor: 5.372

6.  Adenosine 3',5'-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease.

Authors:  H Cramer; L K Ng; T N Chase
Journal:  Arch Neurol       Date:  1973-09

7.  Determination of regional distribution of adenosine 3',5'-monophosphate in rat brain.

Authors:  H Cramer; M I Paul; S Silbergeld; J Forn
Journal:  J Neurochem       Date:  1971-08       Impact factor: 5.372

8.  The effect of oxotremorine and atropine on cGMP and cAMP levels in mouse cerebral cortex and cerebellum.

Authors:  J A Ferrendelli; A L Steiner; D B McDougal; D M Kipnis
Journal:  Biochem Biophys Res Commun       Date:  1970-11-25       Impact factor: 3.575

9.  [Myoclonic encephalopathies induced by bismuth salts. 6 cases observed during long-term oral treatment].

Authors:  A Buge; G Rancurel; M Poisson; H Dechy
Journal:  Nouv Presse Med       Date:  1974-10-26

10.  Disturbed oxidative metabolism in organic brain syndrome caused by bismuth in skin creams.

Authors:  G Krüger; D J Thomas; F Weinhardt; S Hoyer
Journal:  Lancet       Date:  1976-09-04       Impact factor: 79.321

View more
  1 in total

Review 1.  Pharmacokinetics and toxicity of bismuth compounds.

Authors:  A Slikkerveer; F A de Wolff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.